Recent News

• 06.05.2025 - Jefferies Global Healthcare Conference
• 06.05.2025 - Jefferies Global Healthcare Conference
• 05.29.2025 - Septerna to Present at Jefferies Global Healthcare Conference
• 05.29.2025 - Septerna to Present at Jefferies Global Healthcare Conference
• 05.15.2025 - Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
• 05.15.2025 - Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
• 05.14.2025 - Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases
• 05.14.2025 - Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases

Recent Filings

• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2025 - EX-99.1 EX-99.1
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2025 - 8-K Current report
• 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.14.2025 - 8-K Current report
• 05.14.2025 - EX-99.1 EX-99.1
• 05.09.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.29.2025 - ARS Annual Report to Security Holders
• 04.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material